Cargando…

Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer

It is an increasing evidence that long non‐coding RNAs (lncRNAs) are involved in tumour initiation and progression. Here, we analysed RNA‐sequencing data from the Cancer Genome Atlas (TCGA) datasets. Totally, 1176lncRNAs, 245miRNAs and 2081mRNAs were identified to be differentially expressed (DE) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qun, Bian, Yinzhu, Zhu, Yiping, Wan, Li, Kong, Linghui, Hu, Jing, Yang, Mi, Li, Li, Liu, Baorui, Qian, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028851/
https://www.ncbi.nlm.nih.gov/pubmed/31965704
http://dx.doi.org/10.1111/jcmm.14974
_version_ 1783499056599793664
author Zhang, Qun
Bian, Yinzhu
Zhu, Yiping
Wan, Li
Kong, Linghui
Hu, Jing
Yang, Mi
Li, Li
Liu, Baorui
Qian, Xiaoping
author_facet Zhang, Qun
Bian, Yinzhu
Zhu, Yiping
Wan, Li
Kong, Linghui
Hu, Jing
Yang, Mi
Li, Li
Liu, Baorui
Qian, Xiaoping
author_sort Zhang, Qun
collection PubMed
description It is an increasing evidence that long non‐coding RNAs (lncRNAs) are involved in tumour initiation and progression. Here, we analysed RNA‐sequencing data from the Cancer Genome Atlas (TCGA) datasets. Totally, 1176lncRNAs, 245miRNAs and 2081mRNAs were identified to be differentially expressed (DE) in colon cancer tissues compared with normal tissues. CASC21, a novel lncRNA located in 8q24.21 locus, was significantly overexpressed in 30 colon cancer tissues compared with matched normal tissues by qRT‐PCR assay. CASC21 tended to higher expression as the increase of the tumour‐node‐metastasis (TNM) classification. Functionally, CASC21 promoted cell proliferation by regulating cell cycle and enhanced tumour metastasis by epithelial‐mesenchymal transition (EMT) in colon cancer. Mechanism study indicated that CASC21 might be involved in activating WNT/β‐catenin pathway in colon cancer. In addition, we also built a competing endogenous RNA (ceRNNA) network by bioinformatic analysis using TCGA datasets. Together, our results not only provide novel lncRNAs as potential candidates for further study but also prove that CASC21 is an oncogenic regulator through activating WNT/β‐catenin signalling in colon cancer.
format Online
Article
Text
id pubmed-7028851
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70288512020-02-19 Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer Zhang, Qun Bian, Yinzhu Zhu, Yiping Wan, Li Kong, Linghui Hu, Jing Yang, Mi Li, Li Liu, Baorui Qian, Xiaoping J Cell Mol Med Original Articles It is an increasing evidence that long non‐coding RNAs (lncRNAs) are involved in tumour initiation and progression. Here, we analysed RNA‐sequencing data from the Cancer Genome Atlas (TCGA) datasets. Totally, 1176lncRNAs, 245miRNAs and 2081mRNAs were identified to be differentially expressed (DE) in colon cancer tissues compared with normal tissues. CASC21, a novel lncRNA located in 8q24.21 locus, was significantly overexpressed in 30 colon cancer tissues compared with matched normal tissues by qRT‐PCR assay. CASC21 tended to higher expression as the increase of the tumour‐node‐metastasis (TNM) classification. Functionally, CASC21 promoted cell proliferation by regulating cell cycle and enhanced tumour metastasis by epithelial‐mesenchymal transition (EMT) in colon cancer. Mechanism study indicated that CASC21 might be involved in activating WNT/β‐catenin pathway in colon cancer. In addition, we also built a competing endogenous RNA (ceRNNA) network by bioinformatic analysis using TCGA datasets. Together, our results not only provide novel lncRNAs as potential candidates for further study but also prove that CASC21 is an oncogenic regulator through activating WNT/β‐catenin signalling in colon cancer. John Wiley and Sons Inc. 2020-01-20 2020-02 /pmc/articles/PMC7028851/ /pubmed/31965704 http://dx.doi.org/10.1111/jcmm.14974 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhang, Qun
Bian, Yinzhu
Zhu, Yiping
Wan, Li
Kong, Linghui
Hu, Jing
Yang, Mi
Li, Li
Liu, Baorui
Qian, Xiaoping
Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer
title Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer
title_full Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer
title_fullStr Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer
title_full_unstemmed Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer
title_short Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer
title_sort integrative analysis and validation of dysregulated long non‐coding rnas in colon cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028851/
https://www.ncbi.nlm.nih.gov/pubmed/31965704
http://dx.doi.org/10.1111/jcmm.14974
work_keys_str_mv AT zhangqun integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT bianyinzhu integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT zhuyiping integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT wanli integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT konglinghui integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT hujing integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT yangmi integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT lili integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT liubaorui integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer
AT qianxiaoping integrativeanalysisandvalidationofdysregulatedlongnoncodingrnasincoloncancer